Authors' reply to Minisola and colleagues, Kausar, and Sharvill

Affiliations

¹ Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, Rochester, MN 55905, USA kennel.kurt@mayo.edu.
² Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, Rochester, MN 55905, USA.

Comment

Kurt A Kennel et al. BMJ. 2015.

. 2015 Nov 4:351:h5873.

doi: 10.1136/bmj.h5873.

¹ Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, Rochester, MN 55905, USA kennel.kurt@mayo.edu.
² Division of Endocrinology, Diabetes, Nutrition, and Metabolism, Mayo Clinic, Rochester, MN 55905, USA.

No abstract available

Comment on

Bisphosphonates for the prevention and treatment of osteoporosis.
Maraka S, Kennel KA. Maraka S, et al. BMJ. 2015 Sep 2;351:h3783. doi: 10.1136/bmj.h3783. BMJ. 2015. PMID: 26333528 Review.
Calcium and vitamin D nutrition and bisphosphonate treatment.
Sharvill NJ. Sharvill NJ. BMJ. 2015 Nov 4;351:h5872. doi: 10.1136/bmj.h5872. BMJ. 2015. PMID: 26538063 No abstract available.
Risk of atrial fibrillation with bisphosphonate treatment.
Kausar SA. Kausar SA. BMJ. 2015 Nov 4;351:h5870. doi: 10.1136/bmj.h5870. BMJ. 2015. PMID: 26538297 No abstract available.
More on the use of bisphosphonates in the prevention and treatment of osteoporosis.
Minisola S, Cipriani C, Scillitani A, Pepe J. Minisola S, et al. BMJ. 2015 Nov 4;351:h5868. doi: 10.1136/bmj.h5868. BMJ. 2015. PMID: 26538380 No abstract available.